COVID Boosters Protect People With Cancer
By Dennis Thompson HealthDay Reporter

WEDNESDAY, July 23, 2025 — Cancer patients can be very vulnerable to a severe COVID infection, but COVID-19 vaccine boosters can be lifesavers for them, a new study says.
COVID boosters reduced cancer patients’ hospitalizations and ICU stays by 29%, researchers report in JAMA Oncology.
Overall, the vaccine boosters prevented one hospitalization or ICU admission for every 150 to 166 boosted patients, researchers found.
“The reduction in hospitalizations was significant, and the number of patients we needed to treat to see a benefit to the boosters is quite low,” said senior researcher Jan Figueiredo, director of community health and population research at Cedars-Sinai Medical Center in Los Angeles.
“This shows a great benefit to our cancer patients and should encourage patients to discuss vaccination with their healthcare providers,” she said in a news release.
“Their immune systems can be weakened by their disease and the treatments they receive, which is why major health organizations recommend that these patients be vaccinated against COVID-19,” Figueiredo said.
For the new study, researchers analyzed data on more than 161,000 patients treated for cancer in 2022 and 2023 at Cedars-Sinai, Kaiser Permanente Northern California, Northwell Health in New York and the Veterans Health Administration.
Overall, the percentage of cancer patients who got COVID boosters was quite low, Figueiredo said.
By January 2022, 68% had gotten a booster, and only 38% received subsequent boosters that targeted more than one COVID strain.
“Whether this is due to patient concerns about safety or provider uncertainty about whether to administer a vaccine during treatment is not clear,” Figueiredo said. “What is clear is that we need to advocate strongly for vulnerable groups, including cancer patients, to receive these vaccines.”
This is the largest study to date examining the effectiveness of COVID vaccines and boosters among cancer patients, she noted.
“It adds substantially to our understanding of the effectiveness of COVID-19 vaccines, and we will undertake additional studies as vaccine formulations change and new variants emerge so that we can make recommendations that best protect the health of our patients,” Figueiredo said.
Future research will examine vaccine effectiveness in other groups, such as people with autoimmune diseases and those who’ve had organ transplants, the team said.
“There are several different groups whose immune systems have been affected in different ways, which gives us an opportunity to expand further our understanding of how these vaccines work,” Figueiredo said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-24 00:00
Read more

- Measles Outbreak in Kentucky Confirmed
- Subclinical Synovitis Risk Higher in Psoriasis Without Musculoskeletal Involvement
- FDA Sends Warning Letters to Companies Selling Illegal Opioid Compound
- Riliprubart Earns Orphan Drug Designation in the US for Antibody-Mediated Rejection in Solid Organ Transplantation
- GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk
- Some Newer Antiseizure Meds Safer During Pregnancy
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions